Akari Therapeutics, Plc (Nasdaq: AKTX) reported a net loss of $4.8 million for the second quarter ending June 30, 2026 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE